With focus on natural science, technology, and medicine, the Bayer Science and Education Foundation supports those with dedication and claim outstanding achievements in their field. A variety of science awards are available honoring notable research in innovative areas such as chemistry, biochemistry, and medicine. The Foundation rewards scientific excellence with the aim to raise acceptance for technology in a broader public and to make science more popular.
Formerly known as the National Alliance for Research on Schizophrenia and Depression (NARSAD), the Brain and Behavior Research Foundation has awarded nearly $300 million in over 4,000 NARSAD grants to more than 3,000 scientists around the world since 1987.
The Foundation is committed to alleviating the suffering caused by mental illness by awarding grants leading to advances and breakthroughs in scientific research. One hundred percent of donor contributions for research are invested in NARSAD grants leading to discoveries in understanding causes and improving treatments of disorders such as depression, bipolar disorder, schizophrenia, autism, attention-deficit hyperactivity disorder, and anxiety disorders such as obsessive-compulsive and post-traumatic stress disorders.
Funding is focused on four priority areas to better understand and treat mental illness: basic research, new technologies, diagnostic tools/early intervention, and next generation therapies.
With a mission to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases, Bristol-Meyers Squibb considers requests for clinical research trials from all clinical and therapeutic areas, and gives priority to proposals that support medical plans in cardiovascular/metabolics, neuroscience, cancer, immunology, and virology.
Bristol-Meyers Squibb's investigator-sponsored research includes Clinical Research, Non-Interventional Research, Non-Clinical Research, Pediatric Clinical Research, and Immunoscience, Virology, and Oncology MD Research Program.
The Immunoscience, Virology, and Oncology MD Research Program supports studies furthering the science and knowledge of Rheumatology, HIV/AIDS, HBV, and Oncology. Up to $20,000 is awarded for Immunoscience and Oncology fellows, up to $30,000 for Virology fellows, each supporting research-related expenses for a one-year research period.
An independent private foundation dedicated to advancing the biomedical sciences through supporting research and other scientific activities has two primary goals: to help scientists early in their careers develop as independent investigators and to advance fields in the basic biomedical sciences that are undervalued or in need of particular encouragement.
BWF encourages applications from physician-scientists, women, and under-represented minorities. Most awards are made to degree-granting institutions on behalf of individual researchers nominated by their institution.
Conquering cancer through expanded research, applied knowledge, coordinated partnerships, and community commitment is the focus of the Cancer Research Institute. Founded in 1953, $200 million has been provided to nearly 3,000 scientists who have used the funding to conduct laboratory studies, build research teams, and launch clinical trials. Support is offered for scientists at any stage of their career and levels of scientific inquiry, from basic research to coordinated clinical trials.
Awards available include the Cancer Research Institute-Irvington Institute Fellowship Program, established in 1971, is the longest-standing continuous program to support and train young immunologists. The program has awarded 1,227 fellows, two who went on to win the Nobel Prize.
Fellowship appointments are for three years: $50,000 for the first year, $53,000 for the second year, and $57,000 for the third year. Deadlines for applications are April 1 and October 1 annually.More information
The CDC awards nearly 85% of its budget through grants and contracts to help further its mission to promote health and quality of life be preventing and controlling disease, injury, and disability.
Each year the CDC awards approximately $7 billion in over 14,000 separate grant and contract actions. The CDC utilizes grants to assist other health-related and research organizations that contribute to their mission of health promotion through health information dissemination, preparedness, prevention, research, and surveillance.More information
The CRDF is an independent, nonprofit organization promoting international scientific and technical collaboration through grants, technical resources, training, and services. The mission of the CRDF is to promote the application of science and technology to economic growth through partnerships and training that foster invention, innovation, entrepreneurship, and commercialization of technology, and to strengthen university research and education in science and engineering.
The CDMRP is funded through the Department of Defense via annual Congressional legislation known as the Defense Appropriations Act. Funds are added every year during the budget approval cycle by members of the House or Senate in response to requests by consumer advocates and disease survivors.
The CDMRP manages Congressional Special Interest Medical Research Programs (CSI) encompassing breast, prostate, and ovarian cancers, neurofibromatosis, military health, and other specified areas. Since fiscal year 1992, the CDMRP has managed approximately over $6.5 billion in Congressional appropriations for peer-reviewed research aimed to prevent, control, and cure disease. Through fiscal year 2010, approximately 10,719 awards have been made to advance health care solutions via extramural grants, contracts, and cooperative agreements.
When the Cystic Fibrosis Foundation was founded in 1955, children with the disease rarely lived long enough to attend elementary school. With the Foundation's investment in research and comprehensive care, many people with cystic fibrosis can be expected to live into their 30s and beyond.
The Foundation funds more cystic fibrosis research than any other organization, supporting the development of new drugs, improving the quality of life for those with cystic fibrosis, and finding a cure. The Foundation funds and accredits a national care center network that has been recognized by the National Institutes of Health as a model of care for a chronic disease.
In 1989, Cystic Fibrosis Foundation-supported researchers discovered the defective gene that causes cystic fibrosis, and the Foundation also played an integral role in the development and FDA approval of four therapies that are now a routine part of treatment regiments.
The Foundation supports nearly 30 potential new treatments for cystic fibrosis that are currently in developmentMore information
The Dermatology Foundation Research Awards Program offers career development awards, fellowships, and grants that are intended for early academic careers and research efforts of physicians and scientists in dermatology and cutaneous biology. The Foundation provides research support that helps develop and retain tomorrow's teachers and researchers in dermatology, enabling advancement in patient care.
The annual Dermatology Foundation award offering has 13 funding categories supporting all aspects of dermatology, including a new career development award in dermatopathology. A survey conducted by the Foundation revealed that 80 percent of awardees have remained in academics and 86 percent of these individuals received federal funding, and each dollar of career development award funding garnered $10 or more in NIH grant support.More information
The mission of the DDCF is to improve the quality of people's lives through grants supporting the performing arts, environmental conservation, medical research, and the prevention of child abuse. Since 1997, the DDCF has awarded grants totaling more than $1 billion. The Medical Research Program looks to support the prevention, treatment, and cure of human disease.
- E, F, G -